Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
43.79B | 52.54B | 39.79B | 30.28B | 21.10B | Gross Profit |
9.13B | 14.41B | 8.73B | 6.51B | 3.98B | EBIT |
3.28B | 7.61B | 4.08B | 2.73B | 692.24M | EBITDA |
3.54B | 7.91B | 4.25B | 2.85B | 769.24M | Net Income Common Stockholders |
2.20B | 5.71B | 2.88B | 2.05B | 526.65M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
9.93B | 5.10B | 7.03B | 6.44B | 3.92B | Total Assets |
21.21B | 21.81B | 16.54B | 11.52B | 7.48B | Total Debt |
1.05B | 1.07B | 980.70M | 862.43M | 616.61M | Net Debt |
-8.88B | -4.03B | -6.05B | -5.57B | -3.30B | Total Liabilities |
6.73B | 8.28B | 8.14B | 6.04B | 3.64B | Stockholders Equity |
14.39B | 13.46B | 8.34B | 5.43B | 3.79B |
Cash Flow | Free Cash Flow | |||
6.25B | -1.40B | 565.18M | 2.67B | 1.56B | Operating Cash Flow |
6.77B | -1.21B | 976.89M | 2.74B | 1.58B | Investing Cash Flow |
-614.74M | -319.32M | -282.06M | -48.00M | -39.75M | Financing Cash Flow |
-1.32B | -405.00M | -98.60M | -177.04M | -307.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $1.74T | 54.80 | 16.14% | 0.91% | -11.38% | -33.42% | |
71 Outperform | $581.71B | 16.03 | 18.94% | 3.24% | 8.39% | 93.77% | |
67 Neutral | ¥9.38B | 10.14 | 5.05% | 2.50% | -7.87% | ||
66 Neutral | €80.90B | 0.93 | 90.72% | 0.69% | -11.30% | 6369.78% | |
65 Neutral | ¥25.27B | 12.05 | 5.62% | -13.64% | -36.33% | ||
64 Neutral | $4.30B | 11.84 | 5.23% | 249.82% | 4.06% | -10.21% |